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INTRODUCTION
Increased awareness of left ventricular (LV) myocardial 
disease is attributed to the widespread use of non-
invasive imaging modalities (1). Echocardiography is still 
a cornerstone of LV diagnostic imaging because it can 
provide a safe and comprehensive assessment of cardiac 
structure, function, and regional wall motion. However, 
echocardiography is operator-dependent, with a relatively 
low reproducibility, and possible impairment due to a poor 
acoustic window, limited field of vision, and technical 
artifacts (2). Cardiovascular magnetic resonance (CMR) is 
considered the current gold standard for LV morphological 
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and functional assessment due to its accurate measurements 
of the entire volume and mass without echo-window 
dependency. In addition, it has a unique role in noninvasive 
tissue characterization using different pulse sequences (3, 4). 
In the last decade, rapid technical advances in computed 
tomography (CT) have led to the emergence of cardiac 
CT (CCT) as a comprehensive evaluation of anatomy and 
function including the coronary arteries and cardiac 
chambers. Although CCT is not recommended as the primary 
method of choice in cases of suspected LV myocardial 
diseases, CT enables multiplanar reconstructions in any 
desired orientation and can evaluate the echo-window 
limited areas such as the apex, the posterior portion of 
the interventricular septum, and the anterolateral wall. 
Therefore, CCT offers a comprehensive insight into the 
anatomy and function of cardiac chambers (5). Recent 
studies have demonstrated that CCT may be an attractive 
imaging tool for the characterization of LV myocardial 
diseases based on gross morphology, function, and 
enhancement, as well as the extracellular volume fraction 
(ECV). Therefore, CCT is considered complementary to 
echocardiography and CMR (1, 6). In this review, the current 
techniques and uses of CCT for LV myocardial assessment 
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are discussed. The roles of CCT imaging in the diagnosis of 
LV myocardial diseases have also been highlighted. 
Anatomical Assessment of the Left Ventricle 
with CCT
The left ventricle is a conical structure with thick 
tubular walls tapering to a rounded apex. It comprises an 
inlet portion containing the mitral valve and its tension 
apparatus, an apical portion containing fine trabeculations, 
and an outlet portion leading to the aortic valve. 
Normally, the LV free wall is thickest at the cardiac base. 
The ventricular septum is curved, bulging into the right 
ventricular cavity. It is muscular except for a small portion 
immediately beneath the aortic valve (the membranous 
septum). When the left ventricle is viewed in short-
axial cuts, the mitral valve is supported by two groups of 
papillary muscles in the anterolateral and posteromedial 
positions. The bases of the papillary muscles are continuous 
with the muscular trabeculations at the middle-to-apical 
third of the ventricular wall (Fig. 1) (7-9). 
The LV wall consists of three distinct layers: an inner 
endocardium, a middle myocardium, and an outer 
epicardium. The myocardium consists primarily of 
contractile cardiac myocytes, fibroblasts, and an abundant 
extracellular matrix. The left ventricle is subdivided into 
three main segments: the apical, middle, and basal portions. 
This standardized and widely used segmentation of the left 
ventricle into 17 myocardial segments was introduced by 
the American Heart Association (10). The different anatomic 
landmarks partially reflect the distribution of perfusion of 
the myocardium by the coronary arteries. 
Technical Aspects of CCT 
There are two methods to obtain CCT images according 
to electrocardiography (ECG)-gating techniques. In 
prospective ECG-triggered sequential scanning in a “step-
and-shoot” technique, the CT images are acquired in a 
user-selected phase of the patient’s cardiac cycle (usually 
during mid-diastole). This technique does not allow for 
the evaluation of LV function and wall motion (Fig. 2). 
With the retrospective ECG-gated spiral scanning based 
on continuous data acquisition and table movement at 
low table feed (low spiral pitch) or ECG-gated volumetric 
acquisition with a static table (256- and 320-detector-row CT 
scanner), CT images are obtained at multiple phases of the 
cardiac cycle for the assessment of LV functional parameters 
including wall thickness, volume, and mass, and identification 
of LV regional wall motion abnormality (11-13). 
LV volumes and function are evaluated using a triphasic 
injection protocol to opacify all the cardiac chambers 
without streak artifact in the superior vena cava. The total 
contrast volume is usually 50–120 mL. An initial contrast 
media bolus at 5–7 mL/s is followed by either a slower rate 
of contrast media injection at 2 mL/s or a 50%:50% saline/
Fig. 1. Anatomy of left ventricle.
Three-chamber (A) and short-axis (B) MPR CCT images show mitral valve (short arrows), aortic valve (arrowheads), papillary muscles (thick 
arrows), and apical thinning (long arrow). Left ventricle is divided into three portions: inlet, apical, and outlet. Short-axis MPR image (B) is 
obtained at midventricular level. CCT = cardiac computed tomography, MPR = multiplanar reformat 
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contrast media mixture at 5–7 mL/s and a smaller volume 
saline bolus (14). Routine CCT is typically acquired during the 
early arterial phase for coronary artery assessment. However, 
to ensure sufficient myocardial enhancement, the timing 
of image acquisition is calculated by adding approximately 
2–4 seconds to the measured time of peak aortic root 
enhancement (usually 100–150 Hounsfield units [HU]) (15).
Currently, CT perfusion has evolved into a robust 
and non-invasive tool for the detection of myocardial 
ischemia. There are two approaches–static and dynamic–in 
perfusion CT. Static perfusion CT provides a snapshot of the 
myocardial blood volume or myocardial enhancement at a 
single time point during the first-pass of contrast material 
bolus. A true perfusion defect persists throughout multiple 
phases and it is visualized in both systole and diastole. 
These data are also used to identify regional LV wall motion 
abnormality. Static perfusion CT is easily performed on any 
CCT scanner although it is highly dependent on the timing 
of the scan. In addition, cardiac motion artifacts due to 
increased heart rate during adenosine stress have shown 
a significant percentage of patients in static perfusion CT. 
On the other hand, the dynamic first-pass perfusion CT 
reveals myocardial enhancement at multiple time points 
during first-pass of the contrast material and it facilitates 
quantitative analysis of myocardial perfusion. The best cut-
off myocardial blood flow value distinguishing ischemic 
from remote myocardium varies from 75 to 103 mL/100 
mL/min. However, the drawbacks of dynamic perfusion CT 
imaging include higher exposure to radiation (than static 
perfusion CT) and the limited use of CT scanners (256- or 
320-detector-row CT scanners and dual-source Somatom 
Flash and Force CT scanners [Siemens Healthcare, Forchheim, 
Germany]) (16-18).
Delayed-enhancement CCT shares similar pathophysiological 
basis with delayed-enhancement CMR and it facilitates 
the evaluation of LV myocardial viability or scarring 
with additional administration of contrast medium (slow 
injection rate of up to 2 mL/s and volume between 50 
and 90 mL). A delayed scan is usually performed after 
a variable period of 5–15 minutes following the initial 
administration of contrast medium. The amount of contrast 
medium, injection rate, and the delay time are adjusted 
on a case-by-case basis to evaluate for delayed myocardial 
enhancement (19, 20). Decreased tube voltage (100 or 80 
kVp) and prospective ECG triggering reduce the radiation 
exposure and increase the myocardial contrast in delayed-
phase CCT even though the image noise is increased. 
Delayed hyperenhancement is attributed to the slow 
washout of iodinated contrast media from the region of 
infarcted myocardium (Fig. 3) (19-21). Mahnken et al. (22) 
and Gerber et al. (23) showed that delayed-enhancement 
CCT imaging can be used to quantify infarct size strongly 
correlated with CMR-based imaging. ECV is a reproducible 
and novel index for assessment of myocardial fibrosis 
and it is calculated as a ratio of the change in HU of the 
myocardium and the LV blood before (pre-contrast CCT) and 
Fig. 2. Changes in LV wall thickness during mid- and end-diastole.
Wall thickness and chamber dimension of left ventricle need precise measurements, usually in end-diastole. Most CCT is performed in mid-diastole 
to evaluate coronary artery. Interpretation of LV wall thickness may be misleading in mid-diastole (A) compared with that in end-diastole (B). 
LV = left ventricular
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after contrast administration (delayed-enhancement CCT), 
multiplied by (1-hematocrit). This protocol can be added 
to routine CCT with only a small increase in radiation dose. 
It can be used to delineate the myocardial interstitium and 
provides a new diagnostic test for an under-diagnosed and 
treatable cause of LV hypertrophy (LVH) and heart failure 
(24, 25). CCT represents a potential approach to the clinical 
assessment of diffuse myocardial fibrosis, particularly 
in patients with contraindications to CMR imaging. The 
drawback of delayed-enhancement CCT is the increased 
image noise and scan time. The multi-energy CCT can help 
to reduce the image noise and increase the contrast-to-
noise ratio (21). 
There are 4 different types of multi-energy scanners 
available in clinical practice for tissue characterization, 
as follows. 1) Dual-source technology: two X-ray tubes 
are operated at different kVp values (for example, 80 and 
140 kVp); 2) Rapid kVp switching technology: The X-ray 
source switches rapidly between low (80 kVp) and high 
energy (140 kVp) levels at each X-ray projection; 3) Dual 
spin technology: Using a 320-detector-row CT scanner, the 
patient is initially scanned at one energy level (135 kVp) 
and immediately scanned in the same anatomic location 
using a different energy level (80 kVp); 4) Dual layer or 
spectral detector technology: CT contains one X-ray source 
but two layers of detectors with the top layer absorbing low 
energy photons and the bottom layer absorbing high energy 
photons. Multi-energy CT allows the mapping of iodine 
distribution in the myocardium serving as a marker of 
myocardial perfusion (26-28). Delayed iodine enhancement 
imaging has the potential to better evaluate myocardial 
enhancement, which is considered a marker of myocardial 
fibrosis or scarring and detect myocardial infarction (MI) 
and non-ischemic cardiomyopathy more accurately than 
conventional CT. In addition, multi-energy CT enhanced 
the diagnosis of myocardial fibrosis by calculating the ECV 
fraction. Lee et al. (25) demonstrated that the myocardial 
ECV fraction determined with dual-energy equilibrium 
contrast-enhanced CCT was consistent with that of CMR 
imaging and excellent interobserver agreement in per-
subject analysis was observed.
Analysis of LV Function
The quantification of LV function using CCT has 
been validated in prior studies via comparison with 
echocardiography and CMR (29). In normal Korean adults, 
Kang et al. (30) demonstrated that the LV myocardial 
thickness (septal wall thickness, 1.08 ± 0.18 cm vs. 0.90 ± 
0.17 cm; posterior wall thickness, 0.91 ± 0.15 cm vs. 0.78 
± 0.10 cm), LV end-diastolic volume (112.9 ± 26.1 mL vs. 
98.2 ± 21.0 mL), LV end-systolic volume (41.7 ± 14.7 mL vs. 
33.7 ± 12.2 mL), and mass (145.0 ± 29.1 g vs. 107.9 ± 20.0 
g) were significantly greater in men than in women when 
using 320-detector-row CCT, even though these significant 
differences disappeared after normalization for body 
Fig. 3. Infarct imaging using first pass and delayed-enhancement CCT in patient with acute MI in left circumflex territory. 
Short-axis MPR images of first pass (A) and delayed enhancement (B) show fixed subendocardial perfusion defect (arrows) and delayed 
transmural hyperenhancement (arrowheads) in mid-lateral LV wall. Curved MPR coronary CT angiography image (C) shows acute thrombotic 
occlusion (arrows) of proximal left circumflex artery. Subendocardial perfusion defect indicates microvascular occlusion and poor prognosis. MI = 
myocardial infarction
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surface area. The measurement of LV functional parameters 
by CCT can be used as an alternative, particularly in 
cases of equivocal or suboptimal echocardiography or 
contraindications for CMR. However, there is not sufficient 
evidence to recommend CCT as a routine measurement of LV 
functional parameters (11, 12). A wide-detector CT scanner 
with single shot scanning or dual-source CT encompassing 
both cardiac cycles may be used routinely for simultaneous 
functional analyses.
Approach for LV Myocardial Diseases
The evaluation of LV myocardial diseases using the CCT is 
based on LV volumes and function, regional LV wall motion, 
LV wall thickness, and myocardial density with and without 
contrast enhancement (Fig. 4). Generally, image acquisition 
in CCT is performed in mid-diastole to identify coronary 
anomalies or stenoses. Accordingly, interpretation of LV 
diameters and wall thickness may be inadequate, unless 
correct ECG timing is considered at the point of acquisition. 
Nonetheless, in the presence of definite morphological 
abnormalities such as LV wall asymmetry or distinct 
hypertrophy or thinning, the diagnosis may be apparent 
even when the acquisition phase is technically incorrect (1). 
LV Wall Thickness
Measuring LV myocardial thickness is critical for the 
diagnosis and characterization of many cardiovascular 
diseases. Normal values for LV myocardial thickness 
published in the current literature are derived from 
echocardiography and CMR. The thickness of the 
myocardium is commonly measured at the interventricular 
septum at end-diastole. LV trabeculations are excluded 
from the measurement. The reference range of the LV 
septal and posterior wall thickness at end-diastole using 
echocardiography is 0.6–0.9 cm in women and 0.6–1.0 
cm in men (31). In normal Korean adults, the mean LV 
myocardial wall thickness measured on CCT was less than 11 
mm at the septum and 10 mm at the posterior wall (30). 
Diseases Associated with LV Wall Hypertrophy
LVH, defined by the increase in LV mass and LV septal wall 
thickness, is a common cardiac finding generally caused by 
a hemodynamic overload. LVH severity is graded based on 
LV septal wall thickness, indexed LV mass, and LV geometry. 
The reference values for LVH severity in clinical guidelines, 
which are based on echocardiographic measurements, are 
also used for CMR and CCT (31-33).
LVH, frequently defined by interventricular septal and/
or posterior wall thickness at end-diastole > 11 mm, is a 
marker for cardiac disease. LVH is a common pathology 
which requires exhaustive characterization. The exact 
diagnosis and differential diagnosis of LVH is of paramount 
therapeutic and prognostic value. Physiological LVH occurs 
in athletes (Athlete’s heart). Pathological LVH is mainly 
classified into the primary (hypertrophic cardiomyopathy; 
HCM) and secondary types. LVH results in an increased 
afterload (aortic stenosis [AS], aortic insufficiency, and 
hypertension) or myocardial infiltration (amyloidosis, 
Fig. 4. Global and regional LV function assessment with CCT in 51-year-old man with previous MI.
Precontrast CCT image (A) shows curvilinear fat deposition in subendocardium of LV myocardium (arrowheads). Short-axis MPR CCT images 
obtained during end-systole (B) and end-diastole (C) show akinesia, curvilinear fat deposition in subendocardium (arrowheads), and thinned 
myocardium (5 mm in thickness) in mid-anterior and anteroseptal LV wall (arrows). LV ejection fraction, end-diastolic, and end-systolic volumes 
were 57%, 137 mL, and 59 mL, respectively. 
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sarcoidosis, Fabry disease, and cardiac tumors) (33). The basic 
diagnostic approach for LVH depends on the morphological 
characteristics of LVH (symmetrical vs. asymmetrical) (Fig. 5). 
Asymmetrical LVH
Isolated Basal Septal Hypertrophy 
Isolated basal septal hypertrophy (IBSH) involving at 
least 15 mm thickness is occasionally termed a sigmoid 
septum or septal bulge. It is detected in up to 10% of 
cardiac patients without HCM and is more prevalent in the 
elderly population (34). In a study by Ranasinghe et al. 
(35), the presence of IBSH was strongly related to age with 
the observed frequency rising from 1% of people younger 
than 50 years to almost 10% in those aged 80–90 years. 
The frequency of IBSH morphology was 14-fold higher 
than the frequency of typical morphological forms of HCM, 
and 65% of patients had a history of hypertension. A few 
patients with IBSH manifest exertional LV outflow tract 
(LVOT) obstruction and dyspnea, leading to difficulty in 
differentiating IBSH from HCM (35). In a study by Gaudron 
et al. (36) the echocardiographic septal bulge, defined as 
the basal-septal wall thickness ≥ 2 mm thicker than the 
mid-septal wall thickness, strongly predicted hypertension 
with a sensitivity of 93% and specificity of 86%. The septal 
bulge in patients with hypertension is a very early sign of 
hypertensive heart disease. The LVOT and basal-to-middle 
interventricular septum are clearly visualized on 3-chamber 
and short-axis multiplanar reformatted (MPR) images of 
ECG-gated CCT (Fig. 6).
Hypertrophic Cardiomyopathy 
HCM is the most common inheritable primary 
cardiomyopathy that is characterized by unexplained 
diffuse or segmental LVH without compensatory dilatation 
of the LV chamber, and with normal or supernormal systolic 
function (37). Progression to end-stage HCM, known as 
the burnout or dilated phase, is characterized by systolic 
dysfunction, LV dilatation, and wall thinning; it occurs 
in 2.4% to 15.7% of individuals and is associated with 
largely unfavorable prognosis (38, 39). The usual diagnostic 
criterion for HCM is LV maximal wall thickness ≥ 15 mm 
at the end-diastolic phase. Particularly, LV maximal wall 
thickness ≥ 30 mm is associated with sudden cardiac death 
(40). The most common form of HCM is asymmetric septal 
hypertrophy, which is defined as hypertrophy with a septal-
to-inferolateral wall thickness ratio ≥ 1.3. Other forms of 
HCM are focal mass-like, mid-ventricular, and apical (41-43). 
CCT is more accurate than transthoracic echocardiography to 
detect LVH, particularly for the anterior-lateral free wall and 
for the apex. CCT plays a potential role in the assessment of 
HCM based on key morphological characteristics, LV systolic 
Fig. 5. Diagnostic approach based on LV wall thickness using CCT. 
AS = aortic stenosis, COA = coarctation of aorta, DCM = dilated cardiomyopathy, HCM = hypertrophic cardiomyopathy, IBSH = isolated basal septal 
hypertrophy, NCC = non-compaction cardiomyopathy
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function, the extent of myocardial fibrosis with delayed-
enhancement (diffuse or focal enhancement with patchy or 
massive mid-wall), ECV measurement, and the presence of LV 
crypts as well as coronary artery evaluation simultaneously 
(Fig. 7). CCT reveals a thin-walled apical aneurysm showing 
transmural enhancement and intracavitary thrombus in 
patients with apical HCM with burned-out phase (42, 43). 
Sarcoidosis
Sarcoidosis is a multisystemic disorder of unknown cause 
that is characterized histopathologically by noncaseous 
epithelioid granulomas. Granulomas and/or fibrous scars 
tend to be distributed in the subepicardial layer; however, 
they can be present anywhere in the myocardium. LVH in 
a noncoronary distribution is frequent and it mimics HCM 
with asymmetric focal LVH. Sarcoid lesions ultimately heal 
through fibrosis, which leads to myocardial thinning and 
ventricular aneurysm. The myocardial thickness fluctuates 
according to disease activity, with the myocardium thicker 
during the active phase and thinner during the healed 
phase. Thus, it may be difficult to distinguish cardiac 
sarcoidosis from other cardiomyopathies based on delayed-
enhancement pattern and myocardial thickness (44-46). 
CCT reveals the typical morphological features and delayed-
enhancement (multifocal segments with transmural or 
subepicardial distribution) in cardiac sarcoidosis, as well as 
its involvement in other organs (Fig. 8) (47). 
Cardiac Tumor
Primary or secondary tumors located in the left ventricle 
lead to localized LVH. Primary cardiac tumors are rare, 
and the histological types are varied. The incidence of 
metastatic cardiac tumors is 100-fold more common than 
that of primary tumors. Myocardial involvement is a less 
Fig. 6. IBSH of 67-year-old man with diabetes mellitus 
without hypertension. Three-chamber MPR CCT image shows focal 
hypertrophy of basal inter-ventricular septum (arrows) without 
hypertrophy elsewhere within myocardium in mid-diastole on LV 
outflow tract.
Fig. 7. HCM in 57-year-old man with chest pain. 
Short-axis MPR CCT images obtained during early (A) and delayed (B) contrast-enhancement phases show asymmetrical hypertrophy of mid 
anterior, anteroseptal, and anterolateral LV wall (A, arrows) in mid-diastole with multifocal mid-wall delayed enhancement (B, arrows).
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common site of cardiac metastasis (Fig. 9). Benign cardiac 
tumors such as fibroma and rhabdomyoma are homogeneous 
masses with soft tissue attenuation, smooth and well-
defined margins without infiltration. However, malignant 
tumors such as rhabdomyosarcoma and angiosarcoma 
show lobular, ill-defined, and invasive borders and a broad 
attachment to the myocardium. Primary cardiac lymphomas 
with massive myocardial infiltration may show irregular 
thickening of the LV wall that mimic classic HCM (48). CCT 
may facilitate the differentiation between cardiac tumor of 
the LV myocardium and mass-like HCM.
Symmetrical LVH
Sports-Related LVH: ‘Athlete’s Heart’
The term ‘athlete’s heart’ refers to a clinical picture 
characterized by a lower heart rate and cardiac enlargement. 
Long-term exercise training-induced hemodynamic changes 
lead to an increase in both LV dilation and LVH, in order 
to normalize LV wall stress. Accordingly, athlete's heart 
Fig. 8. Cardiac sarcoidosis in 61-year-old woman with irregular cardiac rhythm and dyspnea.
Short-axis MPR CCT images obtained during early (A) and delayed (B) contrast-enhancement phases show concentrically hypertrophied mid-
LV wall in mid-diastole with diffuse transmural and mesocardial delayed enhancement (arrows). Delayed-enhancement CMR image (C) shows 
diffuse mesocardial enhancement in septum and multifocal patchy mesocardial enhancement in mid anterior, lateral, and inferior LV wall (arrows). 
Delayed-enhancement CMR is superior to delayed-enhancement CCT for differentiating patterns of delayed myocardial enhancement. CMR = 
cardiovascular magnetic resonance
A B C
Fig. 9. LV metastasis from lung cancer in 93-year-old man.
Contrast-enhanced chest CT image (A) shows 13-mm lobulated nodule with heterogeneous enhancement in anterior segment of left lower lobe 
(arrow). Mid-diastolic short-axis MPR CCT image (B) shows large infiltrating mass with homogeneous hypoenhancement as focal hypertrophied 
mid inferoseptal and inferior LV wall (arrows).
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can mimic diseases such as HCM or dilated cardiomyopathy 
(DCM). In elite athletes, the LV end-diastolic diameter is 
not frequently increased to > 60 mm (49). In 947 elite 
athletes, the maximal end-diastolic septal wall thickness 
was ≤ 12 mm in most (50). CCT may be used to rule out 
coronary anomalies or coronary artery diseases (CAD) in 
symptomatic athletes (51).
Hypertension
Hypertension is a highly prevalent cardiovascular 
risk factor and it is the most common cause of LVH. 
Echocardiographic LVH is detected in 20–40% of patients 
with hypertension. Hypertensive heart usually shows 
concentric LVH, which is characterized by normal cavity 
size, uniformly increased LV wall thickness and increased 
LV mass. Interventricular septal thickness increases up to 
15 mm. Left atrial dilatation is also seen in hypertension 
(52, 53). In a study by Rodrigues et al. (54), an asymmetric 
end-diastolic wall thickness of ≥ 15 mm and > 1.5-fold 
the opposing myocardial segment in ≥ 1 segment was 
exclusively observed in the basal-to-mid septum in 21% of 
a purely hypertensive cohort. CCT is appropriate for LV wall 
thickness, mass and volume measurement, and for excluding 
CAD in patients with hypertension. 
Aortic Stenosis 
AS is the most common valvular heart disease (VHD) in 
the elderly population. AS increases LV afterload and causes 
compensatory LVH (concentric LVH). LVH causes reversible 
myocardial ischemia and irreversible myocardial injury, 
such as interstitial myocardial fibrosis (55). Accordingly, 
it is increasingly clear that it is also a disease of the 
left ventricle rather than the aortic valve exclusively. 
Usually, the LV wall is symmetrically hypertrophied in AS 
and, occasionally, an area of the LV shows asymmetrical 
septal hypertrophy (Fig. 10) (56). In a study by Tuseth 
et al. (57), asymmetrical septal hypertrophy (defined as 
interventricular septal/posterior wall thickness ratio > 1.5 
on echocardiography) was found in 22% of 1719 patients 
with asymptomatic AS and hypertension was the most 
important predictor of asymmetrical septal hypertrophy and 
asymmetric LVH. 
CCT is a useful imaging modality for severe AS patients 
indicated for transcatheter aortic valve replacement. 
The assessment of LV function and scar imaging of the 
myocardium with CCT has not been routinely established 
in clinical practice (56). Recently, Bandula et al. (24) 
demonstrated a significant correlation between both 
equilibrium CT–derived and equilibrium CMR imaging–derived 
ECV and percentage of histological fibrosis in patients with 
severe AS. Equilibrium CT–derived ECV was significantly 
correlated to equilibrium CMR imaging–derived ECV. 
Amyloidosis
Amyloidosis is a systemic disease characterized by the 
extracellular deposition of pathological and insoluble 
amyloid protein in multiple organs. Approximately 50% 
of patients with immunoglobulin light-chain amyloidosis 
develop cardiac involvement. Cardiac amyloidosis is 
associated with poor prognosis. Myocardial thickening with 
a restrictive diastolic filling pattern is pathognomonic of 
cardiac amyloidosis. A diffusely heterogeneous delayed 
Fig. 10. Severe aortic valve stenosis in 79-year-old man with chest discomfort and shortness of breath. 
Double oblique MPR image of aortic valve (A) shows thickened and calcified cusps (arrowheads) of tricuspid aortic valve with severely reduced 
opening (aortic valve area of 0.98 cm2) during early-systole. Short-axis MPR image (B) shows hypertrophied mid-LV wall, particularly asymmetric 
septal hypertrophy (arrows). Delayed-enhancement CCT image (C) shows extensive mesocardial delayed hyperenhancement in middle LV wall (arrows). 
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hyperenhancement along the areas of amyloid protein 
deposition, predominantly affecting the subendocardium 
and the basal segments, is more specific than the 
morphologic and functional findings (58, 59). CCT reveals 
thickening and subtle lower attenuation of the ventricular 
wall without dilatation. Subendocardial and circumferential 
delayed-enhancement is apparent on delayed-enhancement 
CCT (Fig. 11) (47). In a study by Deux et al. (60), 
myocardial attenuation on delayed-enhancement CCT was 
higher in patients with cardiac amyloidosis (121 ± 39 HU) 
than in control patients (81 ± 17 HU). Dynamic equilibrium 
CT recently showed that the ECV was higher in patients with 
amyloidosis than with AS (0.54 ± 0.11 vs. 0.28 ± 0.04, p < 
0.001) with no overlap and the ECV tracked clinical markers 
of cardiac amyloid severity (6). Accordingly, CCT, like CMR, 
has a potential role in the non-invasive diagnosis and 
quantification of cardiac amyloidosis.
Diseases Associated with LV Wall Thinning
Myocardium thinning is one of the principal signs of 
myocardial damage and ischemia. Even though old MI 
is the most common disease characterized by focal LV 
myocardial thinning, normal anatomical and congenital LV 
wall thinning and other non-coronary heart diseases also 
exhibit focal LV myocardial thinning (1). Several studies 
have focused on the presence of focal thinning as nonviable 
scar tissue in conventional cardiac imaging (61, 62). 
CCT facilitates the differential diagnosis of LV myocardial 
thinning based on the location, asynergy, and presence of 
fibro-fatty changes of thinned LV sites (Fig. 5) (63).
Global LV Wall Thinning
Dilated cardiomyopathy 
DCM, the most common form of non-ischemic 
cardiomyopathy, is characterized by a dilated and poorly 
functioning left ventricle in the absence of CAD, pressure 
overload, or infiltrative cardiomyopathies. Half of the cases 
are idiopathic in nature, with the remainder secondary to 
previous infection, alcohol and drug abuse, or toxicity. 
Sudden cardiac death, which accounts for 10 % of all adult 
sudden cardiac death cases, may be the first manifestation 
of idiopathic DCM (64). 
LV dilatation is a key finding of DCM and is occasionally 
associated with right ventricular dilatation and 
hypertrabeculation of both ventricles. The thickness of 
the LV wall increases or decreases to compensate for 
the dilatation. Occasionally, intracavitary thrombi are 
present in the ventricles. Three types of DCM-related 
delayed-enhancement include mid-wall, subendocardial, 
or transmural. The absence of delayed-enhancement has 
also been reported (65, 66). CCT has been used to evaluate 
the biventricular volumes, wall thinning (diastolic wall 
thickness < 5.5 mm), ventricular mass, and global and 
regional LV functions using the multiphase reconstruction 
of cine images (Fig. 12). Furthermore, CCT allows for the 
characterization of the myocardium and the differentiation 
of DCM patients from LV dysfunction related to CAD by 
providing myocardial delayed-enhancement pattern and ECV 
values of the myocardium (25, 47).
Non-Compaction Cardiomyopathy 
Non-compaction cardiomyopathy (NCC) is characterized 
by the presence of an abnormal noncompacted myocardium 
due to the arrested development of endomyocardial 
compaction. Its prevalence is 0.05 % in the general 
population (67). The morphological findings of NCC are 
numerous and manifest as prominent trabeculations and 
deep intertrabecular recesses that communicate with the LV 
cavity but not with the coronary arteries (68, 69). The most 
frequently involved segments include the apical and mid-
ventricular areas of the inferior and lateral walls of the left 
Fig. 11. Cardiac amyloidosis in 74-year-old male who presented 
with chest pain. Four-chamber MPR delayed enhancement image 
obtained during mid-diastole shows hypertrophy of LV myocardial wall 
and diffuse, concentric subendocardial and transmural enhancement 
(arrowheads) in LV myocardial wall. Case courtesy of HJ Lee, Yonsei 
University Severance Hospital.
343
Assessment of LV Myocardial Diseases with Cardiac CT
https://doi.org/10.3348/kjr.2018.0280kjronline.org
ventricle. The high spatial resolution of CCT facilitates clear 
depiction of trabeculations along the LV wall and LV crypt 
thrombus and it also facilitates an accurate measurement 
of the end-diastolic thickness of the noncompacted and 
compacted myocardium perpendicular to the compacted 
layers of the LV wall (Fig. 13) (70). Melendez-Ramirez et al. 
(71) demonstrated that the presence of a non-compacted-
to-compacted ratio ≥ 2.2 in ≥ 2 myocardial segments is 
diagnostic of NCC. The thickness of the compacted layer was 
significantly lower in the segments with NCC compared with 
the segments without it. 
Localized LV wall Thinning
Myocardial Infarction
MI is a major cause of death and disability worldwide (72). 
The primary cause of acute MI is the sudden disruption 
of an unstable atherosclerotic plaque in the coronary 
artery followed by acute intracoronary thrombosis. The 
infarct progresses from the subendocardium towards the 
epicardium in a wavefront pattern, which may eventually 
become transmural. Regional wall thinning is indicative 
of transmural MI which affects the full thickness of the 
affected muscle segments (73). 
Non-contrast CCT facilitates the detection of chronic MI 
displaying fatty replacement with lower attenuation (HU 
< 0) or myocardial calcification in chronic MI territories. 
Ichikawa et al. (74) demonstrated the presence of adipose 
tissue in the LV wall (94% subendocardium) of the region 
perfused by the infarct-related artery in 33 of 53 MI 
patients (62%) and identified a significant relationship 
with infarct age in patients with previous MI, particularly 
among patients with infarct age ≥ 3 years. Early-phase 
contrast-enhanced CCT shows hypoenhancement due to the 
reduced distribution of contrast medium during the first 
passage in infarcted areas of patients with acute, chronic, 
and subacute MI. Remodeling of the left ventricle, focal 
wall thinning, regional LV wall motion abnormality, or LV 
thrombus or aneurysm may be easily apparent on early-
phase CT (75, 76). Simple measurement of end-diastolic wall 
Fig. 13. NCC in 48-year-old woman with dyspnea and cough 
pain. End-diastolic short-axis MPR image shows increased thickness of 
noncompacted layer in  anterior, lateral, and inferior segments of mid-
LV wall with ratio of noncompacted (black arrow, 15 mm in thickness) 
to compacted myocardium (white line, 6 mm in thickness) > 2.3:1.
Fig. 12. DCM in 63-year-old man. 
Four-chamber MPR image (A) obtained during end-diastole shows all cardiac chamber dilatation. Short-axis MPR CCT images obtained during 
end-systole (B) and end-diastole (C) show LV dilation, thinned myocardium (5 mm in thickness), and global severe hypokinesia. LV ejection 
fraction, end-diastolic, and end-systolic volumes were 12%, 137 mL, and 59 mL, respectively. 
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thickness (< 6 mm) indicates irreversible myocardial damage 
and obviates the need for viability testing such as delayed-
enhancement CMR (77). Nieman et al. (78) demonstrated a 
significantly lower CT attenuation in patients with chronic 
MI (-13 ± 37 HU) compared with those with acute MI (26 
± 26 HU) and normal controls (73 ± 14 HU, p < 0.001). 
The attenuation difference between infarcted and remote 
myocardium was larger in patients with chronic MI than 
in patients with recent MI. In addition, chronic MI was 
associated with wall thinning and ventricular dilation, 
whereas recent MI was not. Cury et al. (79) showed that 
comprehensive CT analysis for the detection of acute MI, 
based on matching perfusion defect and abnormal regional 
wall motion, yielded a sensitivity of 94% and a specificity 
of 97% and showed that the interobserver reliability 
was better with CT when compared with transthoracic 
echocardiography. 
Delayed-enhancement CCT ranging from 5 to 15 minutes 
after the contrast injection led to an accurate estimation of 
infarct size and microvascular occlusion in acute MI (80). 
Sato et al. (81) demonstrated that the size of myocardial-
delayed enhancement on CCT images obtained immediately 
after primary percutaneous coronary intervention was a 
significant and independent predictor of cardiac events 
after adjustment for Thrombolysis In Myocardial Infarction 
risk score, LV ejection fraction, total defect score on single-
photon emission CT with technetium tetrofosmin, and 
transmural extent of delayed-enhancement on CCT. The 
feasibility and short examination time of CCT are considered 
important advantages when compared with CMR. 
LV Aneurysm
LV aneurysm is defined as an outpouching containing 
full thickness of the LV wall with thin, abnormally 
contracting and scarred myocardium with its characteristic 
paradoxical bulging or dyskinesia. LV aneurysm most 
frequently develops after transmural MI, usually involving 
the apical, the anterior, or the anterolateral wall (left 
anterior descending artery territory). CCT findings include 
broad neck (the ratio of the maximum diameter of the 
orifice to the maximum internal diameter of the cavity = 
0.9–1.0), smooth transition from normal myocardium to 
thinned scarred myocardium (delayed-enhancement), and 
paradoxical expansion or dyskinesia. In addition, fatty 
replacement of the infarcted myocardial wall, calcification, 
and intraventricular thrombus formation may be seen in 
chronic aneurysms (Fig. 14). A true aneurysm has a lower 
risk of rupturing when compared with a pseudoaneurysm 
and it is often managed medically (82, 83). 
LV Pseudoaneurysm (a false aneurysm)
It is defined as an outpouching that results from rupture 
of the LV free wall, limited by an overlying adherent 
pericardium without a myocardial layer. Pseudoaneurysms 
are most often attributed to MI following left circumflex 
coronary artery occlusion. However, it may also occur after 
cardiac surgery, trauma, or infection (84). Morphologically, 
pseudoaneurysms are characterized by a neck narrower than 
the diameter of the aneurysm (the ratio of the maximum 
diameter of the orifice to the maximum internal diameter 
of the cavity = 0.25–0.5), an abrupt transition from normal 
myocardium to aneurysm, and a distinct discontinuity 
of the ventricular wall. Generally, the inferior and lateral 
wall segments are involved (Fig. 15). Pseudoaneurysms 
have poor prognoses because of a high risk of rupture, 
thus warranting urgent surgical repair. CCT can distinguish 
between pericardium, thrombus, and the myocardium and 
it can identify akinetic/dyskinetic segments in the LV 
wall and provide diagnostic clues for LV aneurysms and 
pseudoaneurysms (83, 85). 
LV Apical Thin Point
The LV apex is the thinnest part of the LV myocardium 
Fig. 14. LV aneurysm with intracavitary thrombus in 53-year-
old man with chronic MI. Axial CCT image shows thin-walled apical 
aneurysm (arrowheads) and extensive intracavitary thrombus formation 
(arrows).
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in normal and hypertrophied hearts and it is different from 
the cardiac apex (Fig. 1A) (86). Apical thickening is not 
observed throughout the entire cardiac cycle. This extreme 
tip of the apex is difficult to visualize on echocardiography 
but is clearly visible on CCT. In a study by Johnson et al. 
(87), the average thickness of the LV apical thinning was 1.2 
mm in 64 patients using a 64-slice CT scanner. This normal 
anatomical thinning should not be confused with either a 
myocardial scar from an ischemic insult or a congenital LV 
diverticulum.
LV Crypts
Myocardial crypts are defined as narrow, deep blood-
filled invaginations in the compact LV myocardium with a 
penetration > 50% of the thickness of adjoining myocardium 
during diastole and are almost or completely obliterated 
by surrounding tissue during systole. They commonly 
involve the basal and middle segments of the inferoseptal 
LV myocardium, as well as the basal inferior wall and are 
reported in a wide variety of cardiac diseases as well as in 
normal control subjects (Fig. 16) (88). In a study by Child 
et al. (89), crypts were found more frequently in patients 
with hypertensive cardiomyopathy (27%) and HCM (11.7%) 
than in normal control subjects (3.6%). Recent studies 
suggest that the presence of crypts in patients with an 
otherwise normal CMR and a family history of HCM was 
a predictor of ‘gene carrier’ status, with implications for 
genetic testing (90, 91). CCT is a highly sensitive imaging 
tool for the detection of myocardial crypts with MPR images 
from the isotropic volumetric data set covering all portions 
of the left ventricle. 
Congenital LV Diverticulum
Congenital LV diverticulum is a rare cardiac malformation 
(approximately 0.04% in the general population). Despite 
Fig. 15. LV pseudoaneurysm in 65-year-old man with stable 
angina. Two-chamber MPR CCT image shows LV inferior wall 
outpouching with relatively narrow neck (arrowheads), intracavitary 
thrombus (arrows), and multiple calcifications along its wall. 
Fig. 16. LV crypt in 68-year-old man with HCM.
End-diastolic (A) and end-systolic short-axis (B) MPR CCT images show sharp-edged disruption of normal compacted myocardium penetrating 
basal inferior LV wall (A, arrow) with near complete obliteration during end-systole (B, arrow). 
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the absence of symptoms, this malformation may be 
associated with systemic embolization, fatal ventricular 
arrhythmias, and sudden death due to ventricular rupture 
(92). Based on its location, this malformation can be 
classified as fibrous or muscular. The muscular diverticulum 
is more frequent and mostly found in the apical region. It is 
characterized by a finger or hook-like pouch of the entire LV 
myocardial wall with synchronous contractility (Fig. 17). The 
fibrous diverticulum is usually located either in the base of 
the heart or in the subvalvular area. It is characterized by an 
outpouching with a narrow neck, no volume change during 
the cardiac cycle, and the presence of fibrous tissue on the 
diverticulum wall. CCT facilitates accurate diagnosis of LV 
diverticulum based on the location, tissue characteristics, 
and contractility of LV outpouching (93).
Myocarditis
Myocarditis is an acute or chronic inflammatory disease 
of the myocardium. It is an important etiology underlying 
other myocardial diseases such as DCM and arrhythmogenic 
right ventricular cardiomyopathy. Direct myocardial injury 
is accompanied by edema, necrosis, and regional or global 
contractile dysfunction. The late post-inflammatory fibrotic 
phase shows scar formation and irreversible damage to the 
LV wall, as well as LV dilatation (Fig. 18) (94-97).
In patients with acute chest pain, CCT may be used to 
exclude CAD. Delayed-enhancement CCT shows delayed 
hyper-enhancement that is transmural, subepicardial or 
confined to small foci within a layer of the myocardium. 
Delayed-enhancement CT correlates with CMR in acute 
myocarditis based on areas and degrees of involvement. A 
reduced tube voltage increases the contrast of iodine and 
simultaneously lowers radiation exposure (98, 99).
Myocardial Fat
Adults generally display a varying amount of myocardial 
fat without cardiac disease. Physiological myocardial fat 
increases with age and it is considered as part of the normal 
aging process. Cardiac physiologic fat occurs predominantly 
in the right ventricle affecting its anterolateral free 
Fig. 17. LV diverticulum. Three-chamber MPR CCT image shows 
finger or hook-like pouch of entire LV myocardial wall (arrow) arising 
from LV apex in mid-diastole. 
Fig. 18. Myocarditis in 69-year-old man with dyspnea for 10 days.
Initial chest CT (A) shows hypoenhancement in apical to mid interventricular septum (arrows) with preserved myocardial thickness. Short-axis 
MPR CCT image (B) obtained 3 weeks later shows thinned myocardium at anterior, septal, and inferior segments of middle LV wall (arrows). 
Delayed-enhancement cardiac magnetic resonance image (C) obtained 5 weeks later shows transmural hyperenhancement at mid-anterior and 
septal LV wall and subendocardial hyperenhancement at middle inferior LV wall (arrows). 
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wall and outflow tract. Occasionally, the LV apex and 
trabeculae may be affected with small fatty foci (Fig. 19). 
CCT facilitates incidental detection of myocardial fat on 
source axial images of submillimeter thickness and aids the 
differentiation of pathologic from physiologic fat according 
to the characteristic fat patterns, leading to accurate 
diagnosis (100). 
Recognition of patient age, characteristic locations 
of myocardial fat, myocardial thickness, and ventricular 
size facilitate the differentiation of physiological 
and pathological myocardial fat in cardiac imaging. 
Following MI, the scar tissue is progressively replaced 
by fat (lipomatous metaplasia). The fatty replacement 
is associated with infarct age and is frequently seen 
in infarctions older than three years but is absent in 
patients with less than 6-month-old infarcts. CT analysis 
shows that the prevalence of LV myocardial fat is 22–62% 
among patients with a history of MI. Non-enhanced 
or contrast-enhanced CT images show that myocardial 
fat associated with a healed MI is an area of linear or 
curvilinear subendocardial low attenuation in the culprit 
coronary artery, frequently in the LV. It is mostly located 
in the subendocardial myocardium. LV myocardial fat is 
also associated with myocardial thinning or calcification. 
LV myocardial fat in arrhythmogenic right ventricular 
cardiomyopathy appears as a wedge-shaped or bandlike 
configuration in the subepicardial LV-free wall on CT. 
Cardiac lipoma is a benign encapsulated tumor with mature 
adipose tissue and is usually located in the myocardium of 
any cardiac chambers as an asymptomatic fatty mass. DCM 
may also be associated with myocardial fat deposition in 
18–24% of cases (74, 101-103). 
CONCLUSION
The distinction between various LV myocardial diseases 
is of great significance as the management options vary 
considerably with the prognosis. Their characteristic 
features in various imaging modalities show considerable 
overlap. In many forms of myocardial disease, thickening 
and/or thinning of the LV myocardium with fibrosis is a 
common feature. CCT is inferior to CMR in differentiating 
myocardial diseases and myocardial fibrosis, except 
myocardial fat. Especially, most of the restrictive myocardial 
diseases can be normal on CCT. However, the higher spatial 
resolution and volumetric acquisition of CCT allows for the 
depiction of myocardial fat and morphological abnormality 
and has a promising role in the diagnosis of diseases 
affecting the LV myocardium. Recently, myocardial delayed-
enhancement CCT and multi-energy CCT have yielded 
promising results in the detection and characterization of 
various LV myocardial diseases. CCT has potential as an 
adjunct to echocardiography and CMR in the diagnosis of LV 
myocardial diseases in a single sitting.
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